A Single-Arm Clinical Trial of Percutaneous Splenic Ablation Combined With Splenic Artery Occlusion for Secondary Hypersplenism.

Clinical trial NCT06292715 · RECRUITING

Trial details

NCT number: NCT06292715
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Secondary Hypersplenism

Start date: 2024-01-20
Primary completion: 2025-12-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.